CARE vs AMTB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 12, 2026

CARE

62.9
AI Score
VS
CARE Wins

AMTB

59.0
AI Score

Investment Advisor Scores

CARE

63score
Recommendation
BUY

AMTB

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE AMTB Winner
Forward P/E 13.6612 11.4548 AMTB
PEG Ratio 0 0 Tie
Revenue Growth 260.0% 3.3% CARE
Earnings Growth 901.7% 57.1% CARE
Tradestie Score 62.9/100 59.0/100 CARE
Profit Margin 41.8% 14.6% CARE
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CARE

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.